The Controlled Drugs (Drug Precursors)(Intra-Community Trade) Regulations 2008
These Regulations implement Council Regulation (EC) 273/2004 (“the Community Regulation”). The Community Regulation itself requires operators who possess or place on the market a scheduled substance (substances useful for the manufacture of controlled drugs, known as drug precursors) to have a licence where that substance is in Category 1 of Annex I to the Community Regulation and to register where that substance is in Category 2 of Annex I to that Regulation. It permits such licences to be issued either for a specified duration or to be subject to a reporting requirement and permits Member States to operate a special system of licensing and registration for particular persons. The Community Regulation requires operators to appoint a responsible officer before placing on the market a scheduled substance in Category 1 or 2 of Annex I to the Community Regulation and imposes obligations on operators in respect of the documentation, recording and labelling of such substances. It also requires operators to inform the competent authorities of any circumstances which suggest that scheduled substances might be diverted for the illicit manufacture of narcotic drugs or psychotropic substances and to provide those competent authorities every 6 months with a summary of the transactions involving scheduled substances used and supplied in that period.